Showing 1 - 20 results of 67 for search '(( 5 wt decrease ) OR ( 10 ((we decrease) OR (((a decrease) OR (mean decrease)))) ))~', query time: 0.86s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    DAF-16/FOXO is Required for Locomotory Healthspan and Lifespan Benefits of Genetic Glycolysis Disruption. by Brian Onken (86790)

    Published 2020
    “…<i>daf-16</i> mutants are documented to have lowered locomotory ability vs. WT later in life [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.ref091" target="_blank">91</a>, <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.ref092" target="_blank">92</a>]; we note that, although comparison of scores across experiments is not possible due to variation in baseline values, the swimming rate of <i>daf-16(mgDf50)</i> control animals was slightly lower than WT controls on the same day of life (in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.g001" target="_blank">Fig 1C</a>; mean of 46.17 head thrashes/30 sec. for <i>daf-16</i> vs. 52.17 head thrashes/30 sec. for WT on day 10). …”
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Comparison of CBVs in different brain regions of WT and Katnal2-KO mice. by Ryeonghwa Kang (6793046)

    Published 2024
    “…<p>(A) Comparisons of cerebral blood volumes (CBVs) in WT and Katnal2-KO brains, as shown by the extents of decreases in fMRI signals induced by hypoxic nitrogen stimulus in different brain regions (left, relative CBVs) and the KO values normalized to WT values (right, %WT). …”
  17. 17
  18. 18
  19. 19

    Deficiency of the pattern-recognition receptor CD14 protects against joint pathology and functional decline in a murine model of osteoarthritis by Nisha Sambamurthy (703443)

    Published 2018
    “…</p><p>Results</p><p>Early cartilage damage scores 6 weeks post-DMM were similar in both strains (Mean score ±SEM WT: 4.667±1.38, CD14<sup>-/-</sup>: 4.6±0.6), but at 19 weeks were less severe in CD14<sup>-/-</sup> (6.0±0.46) than in WT mice (13.44±2.5, p = 0.0002). …”
  20. 20